HOME >> BIOLOGY >> NEWS
Parasitic worms used to fight bowel disease

EAST LANSING, Mich. Although most of us cringe at the sound of the words "parasitic worms," it's a fact that some of these creatures are actually good for us.

At Michigan State University, researcher Linda Mansfield is part of a national team of scientists investigating the role that parasites can play in treating inflammatory bowel disease, or IBD, in humans.

Her research is part of a more than $10 million National Institutes of Health grant supporting the Food and Waterborne Diseases Integrated Research Network of laboratories launched by the National Institutes of Allergy and Infectious Diseases.

Some researchers argue that improved hygiene throughout the developed world may be responsible for inflammatory bowel disease, as well as a whole range of autoimmune disorders. According to this "hygiene hypothesis," immune systems require exposure to infections of all sorts early in life in order to develop sufficiently.

Intriguingly, inflammatory bowel disease, which has two forms Crohn's disease and ulcerative colitis is virtually unknown in the developing world, while it is increasing dramatically in developed societies. When people from developing countries move to developed ones, their incidence of the disease tends to increase.

"We know from veterinary medicine that many bacterial and protozoan pathogens, especially those that multiply inside of cells, elicit an immune response in the host that would normally cause inflammation, but that worm parasites mount an anti-inflammatory defense that modulates it," said Mansfield, a professor of large animal clinical sciences. "The greater the immune response, the greater the anti-inflammatory effect.

"It's possible that the human immune system developed in a way that is dependent on parasitic worms to regulate immune responses."

The particular worm that Mansfield and colleagues are studying as a potential treatment is known as the whipworm,
'"/>

Contact: Tom Oswald
oswald@msu.edu
517-432-0920
Michigan State University
25-May-2006


Page: 1 2

Related biology news :

1. Parasitic plants sniff out hosts
2. Proteins linked to cancer prevention in humans affect aging in worms
3. Starvation response in worms points to common hunger pathway
4. Carbon nanotube absorption measured in worms, cancer cells
5. Plant cells black out when eaten by leafworms
6. Teaching worms good taste: Researcher reveals the cell biology of learning at ASCB meeting
7. Regenerating worms help elucidate stem cell biology
8. Evolutionary conservation of a mechanism of longevity from worms to mammals
9. Deep sea buffet for bone-devouring worms
10. Allergy-busting worms, cold water corals and the science of Irishness
11. Fluorescing lab worms signal longer life spans, reports CU-Boulder team

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Parasitic worms used fight bowel disease

(Date:3/23/2015)... -- In the 2014 fiscal year, irs.gov recorded over $100 ... accounts for a fraction of the estimated losses for ... $11 billion globally. The polygraph has traditionally been used ... Investor Mark Saint Juste along with former ... partnered to administer the test in a new way: ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are ...
(Date:3/17/2015)... 2015  MecklerMedia Corporation (OTCQX: MECK) announced its ... robots ever held in New York ... 11-13, 2015 at the Javits Convention Center. ... include: Acorn Product Development; Axis NJ; c-Link Systems; ... Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/31/2015)... 2015  Sonoa Health, a health tech startup based ... a world-first consumer health portal, Health&, which brings together ... and more. Today, the Company appointed respected ... who brings to the table more than 18-years experience ... working closely with the biggest names in Silicon Valley ...
(Date:3/31/2015)... NEW YORK , March 31, 2015 /PRNewswire/ ... biopharmaceutical company advancing protein biologic therapies and oncology ... marketing partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: ... the country,s Ministry of Food and Drug Safety ... (KTR) for MuGard, its oncology supportive-care treatment for ...
(Date:3/31/2015)... Diasome Pharmaceuticals, Inc. ( http://www.diasome.com ) ... a United States patent has recently been allowed for ... , Entitled “Lipid Construct for Delivery of Insulin to ... related to the use of Diasome’s proprietary Hepatocyte Directed ... to more effectively reach the liver’s metabolic cells, called ...
(Date:3/30/2015)... March 30, 2015  Multiple new research abstracts suggest ... important health factors. From their impact on colon cancer ... effect on both gut health and vascular health, the ... our latest understanding of walnuts, inner workings. Running March ... , this annual meeting attracts an international audience of ...
Breaking Biology Technology:Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4
Cached News: